Severe infection induces both activation of the coagulation system and multiple other inflammatory mediator cascades. This concise review summarizes the current knowledge of mechanisms that are considered to contribute to the procoagulant response to sepsis. Furthermore, evidence is discussed that mediators traditionally involved in the regulation of the hemostatic balance may also influence other inflammatory pathways.
References
1.
van der Poll T., de Jonge E., Levi M., van Deventer Sjh.Pathogenesis of DIC. Sepsis1999; 3: 103—109.
2.
Franco RF, de Jonge E., Dekkers Pep et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood2000; 96: 554—559.
3.
De Jonge E., Dekkers Pep, Creasey AA et al. Tissue factor pathway inhibitor (TFPI) dose-dependently inhibits coagulation activation without influencing the fibrinolytic and the cytokine response during human endotoxemia. Blood2000; 95: 1124—1129.
4.
Taylor Jr FB , Chang A., Ruf W. et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody . Circ Shock1991; 33: 127—134.
5.
Levi M., ten Cate H., Bauer KA et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest1994; 93: 114—120.
6.
Taylor Jr FB , Chang Ack, Peer G., Ezban M., Hedner U.Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli. Blood1998; 91: 1609—1615.
7.
Creasey AA, Chang Ack, Feigen L., Wün TC, Taylor Jr FB, Hinshaw LBTissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest1993; 91: 2850—2860.
8.
Carr C., Bild GS, Chang Ack et al. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon Gram-negative model of septic shock. Circ Shock1995; 44: 126—137.
9.
Taylor Jr FB , Chang Ack, Peer GT et al. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood1991; 78: 364—368.
10.
van der Poll T., van Deventer Sjh.Cytokines and anti-cytokines in the pathogenesis of sepsis. Infect Dis Clin North Am1999; 13: 413—426.
11.
van der Poll T., Büller HR, ten Cate H. et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects . N Engl J Med1990; 322: 1622—1627.
12.
Jansen PM, Boermeester MA, Fischer E. et al. Contribution of interleukin-1 to activation of coagulation and fibrinolysis, to neutrophil degranulation and the release of sPLA2 in sepsis. Studies in non-human primates following interleukin-1a administration and during lethal bacteremia. Blood1995; 86: 1027—1034.
13.
Lauw FN, Dekkers Pep, te Velde AA et al. Interleukin 12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J Infect Dis1999; 179: 646—652.
14.
van der Poll T., Coyle SM, Levi M. et al. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood1997; 89: 3727—3734.
15.
van der Poll T., Levi M., van Deventer Sjh et al. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood1994; 83: 446—451.
16.
Hinshaw LB, Tekamp-Olson P., Chang Ack et al. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF). Circ Shock1990; 30: 279—292.
17.
Stouthard Jml , Levi M., Hack CE et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost1996; 76: 738—742.
18.
van der Poll T., Levi M., Hack CE et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med1994; 179: 1253—1259.
19.
Pajkrt D., van der Poll T., Levi M. et al. Interleukin 10 inhibits activation of coagulation and fibrinolysis during human endotoxemia. Blood1997; 89: 2701—2705.
20.
van der Poll T., Jansen PM, Montegut WJ et al. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol1997; 158: 1971—1975.
21.
Taylor Jr FB , Chang A., Esmon T., D'Angelo A., Vigano-D'Angelo S., Blick KEProtein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon . J Clin Invest1987 ; 79: 918—925.
22.
Taylor Jr FB , Stearns-Kurosawa J., Kurosawa S. et al. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis . Blood2000; 95: 1680—1686.
23.
Esmon CTIntroduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?Blood2000; 95: 1113—1116.
24.
Bernard GR, Vincent JL, Laterre PF et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med2001:344:699—709
